BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2952855)

  • 1. T-lymphocyte clones from leprosy skin lesions.
    Modlin RL; Gersuk GM; Nelson EE; Pattengale PK; Gunter JR; Chen L; Cooper CL; Bloom BR; Rea TH
    Lepr Rev; 1986 Dec; 57 Suppl 2():143-7. PubMed ID: 2952855
    [No Abstract]   [Full Text] [Related]  

  • 2. T lymphocyte subsets in the skin lesions of patients with leprosy.
    Modlin RL; Hofman FM; Taylor CR; Rea TH
    J Am Acad Dermatol; 1983 Feb; 8(2):182-9. PubMed ID: 6219136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK
    J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-lymphocytes in leprosy lesions.
    Mehra V; Modlin RL
    Curr Top Microbiol Immunol; 1990; 155():97-109. PubMed ID: 2137768
    [No Abstract]   [Full Text] [Related]  

  • 7. T-lymphocyte subsets in leprosy.
    Gonzalez-Amaro R; Moncada B; Loredeo CE; de Lourdes Baranda M
    Int J Dermatol; 1983 Jun; 22(5):305-6. PubMed ID: 6223893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lepromin-induced suppressor cells in patients with leprosy.
    Mehra V; Mason LH; Fields JP; Bloom BR
    J Immunol; 1979 Oct; 123(4):1813-7. PubMed ID: 158056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II restricted helper and suppressor clones reactive with Mycobacterium leprae.
    de Vries RR; Ottenhoff TH; Li SG; Young RA
    Lepr Rev; 1986 Dec; 57 Suppl 2():113-21. PubMed ID: 2952853
    [No Abstract]   [Full Text] [Related]  

  • 10. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
    N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated suppressor T cells in leprosy.
    Mehra V; Convit J; Rubinstein A; Bloom BR
    J Immunol; 1982 Nov; 129(5):1946-51. PubMed ID: 6214583
    [No Abstract]   [Full Text] [Related]  

  • 12. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impressions on the expression of suppression in leprosy.
    Godal T; Mustafa AS; Haregewoin A
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):510-4. PubMed ID: 6231258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lymphocyte sensitization to lepromin in patients with polar types of leprosy].
    Podoplelov II; Selezneva SP
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):82-4. PubMed ID: 6969506
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Kaplan G; Sheftel G; Job CK; Mathur NK; Nath I; Cohn ZA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5210-4. PubMed ID: 2969108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte subsets in leprosy. A study of 24 Egyptian patients.
    Ashamalla L; Yang SJ; Michel M; Rafla L
    Int J Dermatol; 1989 Sep; 28(7):451-3. PubMed ID: 2528512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The granulomatous response of leprosy patients to lepromin and killed BCG.
    Han SH; Kuo SL; Hu SC; Lu ST
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):121-7. PubMed ID: 7004801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships.
    Alcaïs A; Sanchez FO; Thuc NV; Lap VD; Oberti J; Lagrange PH; Schurr E; Abel L
    J Infect Dis; 2000 Jan; 181(1):302-8. PubMed ID: 10608779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ characterization of cells in the dermal infiltrates of lepromin reaction using monoclonal antibodies.
    Narayanan RB; Ramu G; Malaviya GN; Sengupta U; Desikan KV
    Indian J Lepr; 1985; 57(2):265-72. PubMed ID: 3908574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cells of mouse and man. What is the evidence that they contribute to the aetiology of the mycobacterioses?
    Rook GA
    Lepr Rev; 1982 Dec; 53(4):306-12. PubMed ID: 6185812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.